These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
269 related items for PubMed ID: 8441822
21. Inhibitory effects of octreotide on luminal cholecystokinin-releasing factor, plasma cholecystokinin, and pancreatic secretion in conscious rats. Miyasaka K, Masuda M, Kanai S, Ohta M, Suzuki S, Tateishi K, Funakoshi A. Pancreas; 2002 Apr; 24(3):269-75. PubMed ID: 11893935 [Abstract] [Full Text] [Related]
23. Effect of L-364,718 on GRP-stimulated pancreatic and gastric secretions and GI peptides in conscious dogs. Hosotani R, Chowdhury P, Huang YS, McKay D, Yajima H, Rayford PL. Pancreas; 1989 Apr; 4(5):550-5. PubMed ID: 2813326 [Abstract] [Full Text] [Related]
24. The effect of antagonist of receptors for gastrin, cholecystokinin and bombesin on growth of gastroduodenal mucosa and pancreas. Dembiński A, Warzecha Z, Konturek SJ, Banas M, Cai RZ, Schally AV. J Physiol Pharmacol; 1991 Sep; 42(3):263-77. PubMed ID: 1665365 [Abstract] [Full Text] [Related]
25. The action of scretin, cholecystokinin-pancreozymin and caerulein on pancreatic secretion in the rat. Dockray GJ. J Physiol; 1972 Sep; 225(3):679-92. PubMed ID: 5076393 [Abstract] [Full Text] [Related]
26. Involvement of endogenous cholecystokinin and somatostatin in gastroprotection induced by intraduodenal fat. Brzozowski T, Konturek PC, Konturek SJ, Kwiecién S, Pajdo R, Brzozowska I, Hahn EG. J Clin Gastroenterol; 1998 Sep; 27 Suppl 1():S125-37. PubMed ID: 9872509 [Abstract] [Full Text] [Related]
27. Inhibition of unstimulated exocrine pancreatic secretion by peptide YY in the rat. Robinson DC, Rudnicki M, Tito JM, Gold MS. World J Surg; 1996 Feb; 20(2):208-14. PubMed ID: 8661819 [Abstract] [Full Text] [Related]
28. Different effects of trypsin inhibitors on intestinal gene expression of secretin and on pancreatic bicarbonate secretion in CCK-A-receptor-deficient rats. Kawanami T, Suzuki S, Yoshida Y, Kanai S, Takata Y, Shimazoe T, Watanabe S, Funakoshi A, Miyasaka K. Jpn J Pharmacol; 1999 Dec; 81(4):339-45. PubMed ID: 10669038 [Abstract] [Full Text] [Related]
29. Intracolonic infusion of bile salt stimulates release of peptide YY and inhibits cholecystokinin-stimulated pancreatic exocrine secretion in conscious dogs. Izukura M, Hashimoto T, Gomez G, Uchida T, Greeley GH, Thompson JC. Pancreas; 1991 Jul; 6(4):427-32. PubMed ID: 1876599 [Abstract] [Full Text] [Related]
30. Elevation of plasma peptide YY and pancreatic juice hypersecretion following massive small bowel resection in the rat. Imamura M, Takahashi H, Mikami Y, Yamauchi H. Tohoku J Exp Med; 1998 Jan; 184(1):49-59. PubMed ID: 9607398 [Abstract] [Full Text] [Related]
31. Role of cholecystokinin in the negative feedback control of pancreatic enzyme secretion in conscious rats. Fölsch UR, Cantor P, Wilms HM, Schafmayer A, Becker HD, Creutzfeldt W. Gastroenterology; 1987 Feb; 92(2):449-58. PubMed ID: 2431952 [Abstract] [Full Text] [Related]
32. PYY inhibits CCK-stimulated pancreatic secretion through the area postrema in unanesthetized rats. Deng X, Guarita DR, Pedroso MR, Kreiss C, Wood PG, Sved AF, Whitcomb DC. Am J Physiol Regul Integr Comp Physiol; 2001 Aug; 281(2):R645-53. PubMed ID: 11448870 [Abstract] [Full Text] [Related]
33. Comparison of the effects of two cholecystokinin-receptor antagonists, loxiglumide and L-364,718, on the pancreatic secretory response to intraduodenal tryptophan in dogs. Niebergall-Roth E, Teyssen S, Wetzel D, Hartel M, Beglinger C, Riepl RL, Singer MV. Scand J Gastroenterol; 1996 Jul; 31(7):723-32. PubMed ID: 8819225 [Abstract] [Full Text] [Related]
34. Endogenous nitric oxide mediates pancreatic exocrine secretion stimulated by secretin and cholecystokinin in rats. Jyotheeswaran S, Li P, Chang TM, Chey WY. Pancreas; 2000 May; 20(4):401-7. PubMed ID: 10824696 [Abstract] [Full Text] [Related]
35. Pancreatic atrophy in rats produced by the cholecystokinin-A receptor antagonist devazepide. Nylander AG, Chen D, Ihse I, Rehfeld JF, Håkanson R. Scand J Gastroenterol; 1992 Sep; 27(9):743-7. PubMed ID: 1411279 [Abstract] [Full Text] [Related]
36. Evidence for autoregulation of cholecystokinin secretion during diversion of bile pancreatic juice in rats. Li Y, Hao Y, Owyang C. Gastroenterology; 1995 Jul; 109(1):231-8. PubMed ID: 7797020 [Abstract] [Full Text] [Related]
37. Regulation of gene expression of pancreatic secretory trypsin inhibitor-61 and -56 by bile and pancreatic juice in rats. Miyasaka K, Funakoshi A, Nakamura E, Teraoka H. Pancreas; 1995 Oct; 11(3):246-55. PubMed ID: 8577678 [Abstract] [Full Text] [Related]
39. Effect of a novel cholecystokinin receptor antagonist, FK480, administered intraduodenally, on pancreatic secretion in rats. Moriyoshi Y, Shiratori K, Takeuchi T, Watanabe S. Pancreas; 1995 Apr 09; 10(3):295-300. PubMed ID: 7542771 [Abstract] [Full Text] [Related]
40. Effect of proglumide, a cholecystokinin receptor antagonist, on caerulein-stimulated pancreatic enzyme secretion and pancreatic polypeptide release in the dog. Fried M, Beglinger C, Koehler E, Whitehouse I, Varga L, Gyr K. Regul Pept; 1984 Mar 09; 8(2):117-22. PubMed ID: 6729149 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]